Universe Pharmaceuticals INC

Gang Lai, CEO and Chairman of Universe Pharmaceuticals, has increased his beneficial ownership to 13.58% through direct holdings and a controlled entity, following an equity grant.

Sabby Management, Sabby Volatility Warrant Master Fund, and Hal Mintz have jointly disclosed a passive 4.9% beneficial ownership in Universe Pharmaceuticals INC's Ordinary Shares as of December 31, 2025.

Anson Funds Management LP and its affiliated entities, including Anson Management GP LLC, Anson Advisors Inc., and key individuals Tony Moore, Amin Nathoo, and Moez Kassam, have disclosed a collective beneficial ownership of 0.98% of Universe Pharmaceuticals, Inc.'s Ordinary Shares.

Anson Funds Management LP and its affiliates have reported a 9.9% beneficial ownership stake in Universe Pharmaceuticals, Inc., held for ordinary course of business purposes.

Sabby Management, LLC, Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz have jointly disclosed a 9.9% beneficial ownership stake in Universe Pharmaceuticals INC, held for passive investment purposes.